Prevention of Doxorubicin-Induced Hair Loss with Scalp Hypothermia

New England Journal of Medicine

Volumn 301, Issue 26, 1979, Pages 1427-1429

  Dean, Judith C ^a   Salmon, Sydney E ^a   Griffith, Katherine S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADVERSE DRUG REACTION; DRUG INDUCED DISEASE; HAIR LOSS; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; PREVENTION; PREVENTIVE MEDICINE; SCALP; THERAPY;

EID: 0018630995     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197912273012605     Document Type: Article

References (13)

1. Wasserman TH, Comis RL, Goldsmith M, et al: Tabular analysis of the clinical chemotherapy of solid tumors. Cancer Chemother Rep 6: 399–419, 1975
2. Blum RH, Carter SK: Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med 80: 249–259, 1974
3. Dreizen S, Bodey GP, Rodriquez V, et al: Cutaneous complications of cancer chemotherapy. Postgrad Med 58(6):150–158, 1975
4. Jones SE, Durie BGM, Salmon SE: Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36: 90–97, 1975
5. Lloyd RE, Jones SE, Salmon SE, et al: Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial. Cancer Treat Rep 60: 77–83, 1976
6. Wendt A, Jones SE, Salmon SE, et al: Adjuvant treatment of breast cancer with adriamycin-cyclophosphamide with or without radiation therapy, Adjuvant Therapy of Cancer II. Edited by SE Jones, SE Salmon. New York, Grune & Stratton, 1979, pp 285–293
7. Luce JK, Raffetto TJ, Crisp M, et al: Prevention of alopecia by scalp cooling of patients receiving adriamycin. Cancer Chemother Rep 57: 108, 1973
8. Edelstyn GA, MacDonald M, MacRae KD: Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet 2: 253–254, 1977
9. Hill BT, Price LA, Goldie JH: The value of adriamycin in overcoming resistance to methotrexate in tissue culture. Eur J Cancer 12: 541–549, 1976
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958
11. Cetas TC, Connor WG: Thermometry considerations in localized hyperthermia. Med Phys 5: 79–91, 1978
12. Chen H-SG, Gross JF: Physiologically based pharmacokinetic models for anticancer drugs. Cancer Chemother Pharmacol 2: 85–94, 1979
13. Single Agents in Cancer Chemotherapy. Edited by RB Livingston, SK Carter. New York, Plenum Publishing Corporation, 1970, pp 25–80